The PCR-based Septin9 methylation assay, approved for early detection of colorectal cancer (CRC) in the USA, Europe, and China, measures plasma methylation levels of a CpG-rich fragment located in the Septin9 gene promoter [19]. The gene discussed is SEPTIN9; the disease is colorectal cancer.